Mari Levula
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Protease and Inhibitor Mechanisms
- Biological Psychiatry top 10%
- Tryptophan and brain disorders
Papers in
- Surgery 5
- Infectious Aortic and Vascular Conditions 2
- Lipoproteins and Cardiovascular Health 2
- Co-authors
- Terho Lehtimäki (22 shared papers)Mika Kähönen (16 shared papers)Reijo Laaksonen (15 shared papers)Niku Oksala (14 shared papers)Emma Raitoharju (10 shared papers)Leo‐Pekka Lyytikäinen (7 shared papers)Norman Klopp (7 shared papers)Pekka J. Karhunen (6 shared papers)
In The Last Decade
Mari Levula
22 papers receiving 1.0k citations
Mari Levula's Hit Papers
Peers
Comparison fields: 5 of 81
- Cancer Research 346
- Biological Psychiatry 40
- Immunology 181
- Immunology and Allergy 47
- Molecular Biology 450
Countries citing papers authored by Mari Levula
This map shows the geographic impact of Mari Levula's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mari Levula with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mari Levula more than expected).
Fields of papers citing papers by Mari Levula
This network shows the impact of papers produced by Mari Levula. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mari Levula. The network helps show where Mari Levula may publish in the future.
Co-authors
The 25 scholars most cited alongside Mari Levula, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | miR-21, miR-210, miR-34a, and miR-146a/b are up-regulated in human atherosclerotic plaques in the Tampere Vascular Study Hit paper breakdown → | 2011 | 389 |
| 2 | 2011 | 71 | |
| 3 | 2009 | 69 | |
| 4 | 2009 | 61 | |
| 5 | 2017 | 41 | |
| 6 | 2010 | 41 | |
| 7 | 2009 | 38 | |
| 8 | 2015 | 36 | |
| 9 | 2013 | 35 | |
| 10 | 2015 | 31 | |
| 11 | 2009 | 30 | |
| 12 | 2008 | 29 | |
| 13 | 2006 | 24 | |
| 14 | 2017 | 20 | |
| 15 | 2011 | 18 | |
| 16 | 2011 | 18 | |
| 17 | 2011 | 17 | |
| 18 | 2010 | 17 | |
| 19 | 2012 | 14 | |
| 20 | 2013 | 13 |
About Mari Levula
Mari Levula is a scholar working on Molecular Biology, Surgery, Epidemiology, Cancer Research and Pathology and Forensic Medicine, having authored 22 papers that have together received 1.0k indexed citations. Recurring topics across this work include Aortic Disease and Treatment Approaches (2 papers), Aortic aneurysm repair treatments (2 papers), Infectious Aortic and Vascular Conditions (2 papers), Lipoproteins and Cardiovascular Health (2 papers), Protease and Inhibitor Mechanisms (2 papers), Multiple Sclerosis Research Studies (2 papers), Cytomegalovirus and herpesvirus research (1 paper) and Cell Adhesion Molecules Research (1 paper). The work is most often cited by research in Cancer Research (346 citations), Biological Psychiatry (40 citations), Immunology (181 citations), Immunology and Allergy (47 citations) and Molecular Biology (450 citations). Mari Levula has collaborated with scholars based in Finland, Germany and Türkiye. Frequent co-authors include Terho Lehtimäki, Mika Kähönen, Reijo Laaksonen, Niku Oksala, Emma Raitoharju, Leo‐Pekka Lyytikäinen, Norman Klopp, Pekka J. Karhunen, Thomas Illig and Ari Mennander. Their work appears in journals such as Atherosclerosis, Annals of Medicine, Scandinavian Journal of Clinical and Laboratory Investigation, Scientific Reports and European Heart Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.